By expenditures
| Name | Title | Type |
|---|---|---|
| Brenda Arnett | Director of Finance and HR | Auditee |
| Mel Nettesheim | Director Of Finance And Hr | Auditee |
| Shannon D Small | Signing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 388448 | 2025 | 2026-02-23 | CLIFTONLARSONALLEN LLP | $3.70M |
| 337427 | 2024 | 2025-01-13 | Cliftonlarsonallen LLP | $2.00M |
| 302204 | 2023 | 2024-04-02 | Cliftonlarsonallen LLP | $1.82M |
| 52248 | 2022 | 2023-03-30 | Cliftonlarsonallen LLP | $3.06M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 302204 | 2023 | 2024-04-02 | 968518 | 2023-003 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 968517 | 2023-002 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 968516 | 2023-003 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 968515 | 2023-002 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 968514 | 2023-003 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 968513 | 2023-002 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 392076 | 2023-003 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 392075 | 2023-002 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 392074 | 2023-003 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 392073 | 2023-002 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 392072 | 2023-003 | Significant Deficiency | Yes | I |
| 302204 | 2023 | 2024-04-02 | 392071 | 2023-002 | Significant Deficiency | Yes | I |
| 52248 | 2022 | 2023-03-30 | 637222 | 2022-003 | Significant Deficiency | - | I |
| 52248 | 2022 | 2023-03-30 | 637221 | 2022-002 | Material Weakness | - | I |
| 52248 | 2022 | 2023-03-30 | 637220 | 2022-003 | Significant Deficiency | - | I |
| 52248 | 2022 | 2023-03-30 | 637219 | 2022-002 | Material Weakness | - | I |
| 52248 | 2022 | 2023-03-30 | 637218 | 2022-003 | Significant Deficiency | - | I |
| 52248 | 2022 | 2023-03-30 | 637217 | 2022-002 | Material Weakness | - | I |
| 52248 | 2022 | 2023-03-30 | 60780 | 2022-003 | Significant Deficiency | - | I |
| 52248 | 2022 | 2023-03-30 | 60779 | 2022-002 | Material Weakness | - | I |
| 52248 | 2022 | 2023-03-30 | 60778 | 2022-003 | Significant Deficiency | - | I |
| 52248 | 2022 | 2023-03-30 | 60777 | 2022-002 | Material Weakness | - | I |
| 52248 | 2022 | 2023-03-30 | 60776 | 2022-003 | Significant Deficiency | - | I |
| 52248 | 2022 | 2023-03-30 | 60775 | 2022-002 | Material Weakness | - | I |